- Case report
- Open Access
Chew and spit (CHSP) in bariatric patients: a case series
Journal of Eating Disorders volume 9, Article number: 89 (2021)
Studies into the disordered eating behaviour of chew and spit have alluded to several cohorts more likely to engage in the behaviour, one such group being bariatric surgery candidates and patients. Weight-loss surgery candidates have received little to no attention regarding engaging in chew and spit behaviour. Changes in pre- and post- surgery eating pathology related to chew and spit behaviour has yet to be explored and described in academic literature.
The current study reports on three cases of individual women, aged 30, 35, and 62 respectively, who indicated engagement in chew and spit. All three cases underwent bariatric surgery (two underwent gastric bypass, one underwent vertical sleeve gastrectomy). Eating pathology—including chew and spit behaviour, anxiety and depression, and adherence to the Norwegian nutritional guidelines were examined pre-operatively and post-operatively (one and two-year follow-up). At baseline (pre-surgery), two participants reported that they engaged in chew and spit, compared to one patient post-surgery. All three cases reported that they, to at least some extent, adhered to dietary guidelines post-surgery. Subjective bingeing frequency appeared to be relatively low for all three cases, further declining in frequency at one-year follow-up. At baseline, one participant reported clinically significant depression and anxiety, with no clinically significant depression or anxiety reported at follow-ups in participants that chew and spit.
The current study provides a starting point for the exploration of chew and spit as a pathological symptom of disordered eating in bariatric patients. It highlights the need to further explore chew and spit before and after weight-loss surgery.
Weight-reduction procedures have been increasing in popularity in recent years . Bariatric surgery is a procedure performed to aid patients in achieving weight loss and to minimize risk of obesity-related health complications . Weight loss is achieved by one of two mechanisms: the first mechanism being a reduction in stomach capacity by removing a substantial portion of the stomach, such as Vertical Sleeve Gastrectomy (VSG). The second mechanism is through malabsorption, where part of the intestine is bypassed so that less absorption occurs, such as Roux-en-Y gastric bypass .
Most often, bariatric surgery is recommended for individuals who have a BMI over 40 kg/m2 (or > 35kg/m2 with medical comorbidity) who have otherwise been unable to lose weight or maintain weight loss using conventional methods such as behavioural and pharmacological treatments .
According to Williams-Kerver et al. Williams-Kerver, Steffen, & Mitchell  several disturbed eating behaviours and eating disorders (EDs) have been noted in individuals prior to bariatric surgery, which often significantly reduce post-operatively [5, 10, 22, 27, 30]. Of specific note, Bulimia Nervosa (BN) and associated compensatory behaviours (e.g. vomiting, misuse of laxative and diuretics), loss of control (LoC) eating (i.e. feeling unable to stop eating, or to control what and how much one eats), objective and subjective binge eating, and night eating are more prevalent in pre-operative versus post-operative bariatric patients . Perhaps most prevalent among the pre-operative disorders in bariatric patients is Binge Eating Disorder (BED) .
Although disordered eating behaviours associated with loss of control (LoC) are particularly prevalent in bariatric surgery candidates, objective binge eating tends to drastically reduce post-operatively as patients will have reduced stomach capacity . However, other pathological eating behaviours may go unnoticed due to the change in presentation of disordered eating pathology after surgery . Recent studies have suggested certain disordered eating behaviours may increase postoperatively, leading to potential physical and psychological complications, and reduced adherence to post-operative eating guidelines [1, 35]. One such behaviour is “Chew and Spit” (CHSP). CHSP is a behaviour characterised by masticating food and expelling the contents of the mouth before swallowing . CHSP is most often used as a weight control measure and allows the individual to taste the food without ingesting it fully.
Studies into CHSP  have reported individuals with EDs [2, 14, 23, 33], adolescents and young people , and those who may have particular dietary requirements due to surgical interventions or other medical necessity  are more likely to engage in CHSP behaviour. It is this last group that appears to have received least attention to date, in particular individuals who have had weight loss surgery.
A study conducted by D’Souza et al.  has investigated a range of pre- and postoperative disordered eating behaviours, which reduced within the two years prior surgery. However, no prior study has focused on the occurrence of CHSP, or its psychopathological correlates in bariatric surgery patients. Given its modest prevalence rate among the general population , the study of CHSP in bariatric patients who are prone to engage in disordered eating behaviours and have to adhere to strict postoperative dietary guidelines, is warranted. Therefore, the aim of this descriptive and exploratory study is to gain preliminary insight into CHSP in a bariatric sample. As the nature of the current study is exploratory, no specific hypotheses have been developed.
The identification of pathological eating behaviours in bariatric surgery treatment is important in order to identify subgroups of patients presenting with vulnerabilities that limit optimal weight loss if not addressed and treated properly in follow-up regimens. Relevant to the present study, these behaviours may arise and subsequently go unresearched due to limitations of utilised measurements [18, 19] or non-disclosure of eating pathology . Importantly, given that no specific psychological intervention has been developed to target CHSP, nor have existing treatments been tested in individuals who CHSP let alone in bariatric surgery patients, it is paramount that we understand if, and how, CHSP is implicated in worsening eating pathologies pre- and post- operatively.
Given the limited knowledge base surrounding CHSP and bariatric surgery, as well as the potential hampering of weight-loss efforts in individuals who have undergone bariatric surgery  the primary aim of the current study was to explore and describe the phenomena as it may appear in bariatric patients before and after surgery, and to provide directions for future research. The current report examines three individuals who have undergone bariatric surgery and who have admitted to engaging in CHSP behaviour either before or after their procedure. This case series follows the CARE Guidelines for case reporting .
The following measures were used to assess patients pre- and post- operatively :
Prior to undergoing bariatric surgery, participants’ eating pathology and attitudes were assessed using three items (13, 14, & 15) of the Eating Disorder Examination Questionnaire (EDE-Q; . The EDE-Q measures disordered eating behavior in the preceding 28-days, and is a self-report measure of severity and frequency of behaviors using a 7-point Likert scale (0 = No days/Not at all to 6 = Everyday/Markedly), with higher scores reflecting stronger severity and duration over the previous 28-days . The three items used from the EDE-Q included looking at frequency of overeating eating (item 13), frequency of subjective Loss of Control during an overeating episode (LoC,item 14), and the number of days (items 13 and 14 indicated ‘number of episodes’, not number of days—meaning participants could report multiple episodes a day) participants experienced both overeating and LoC (item 15, . In the current study, the three-items used for this measure had excellent internal reliability for both males (α = 0.87) and females (α = 0.87) (total α = 0.82) , .
EDE-Q: BSV (CHSP frequency)
Once participants had undergone surgery (12 months post-operative), eating pathology was assessed using the Eating Disorder Questionnaire: Bariatric Surgery Version (EDE-Q: BSV; [9, 13, 29]. Similar to the standard EDE-Q, the EDE-Q: BSV measures ED behavior across five subscales – dietary restraint, eating concerns, shape/weight overvaluation, and appearance concern—over the past 28-days, with participants rating the severity and frequency of pathological eating behaviors on a 7-point Likert scale . Although the EDE-Q: BSV is closely related to the standard EDE-Q, it more accurately and comprehensively assesses eating pathology in a bariatric population by focusing on post-operative behaviors. Notably the EDE-Q: BVS compares the presence of pre- and post- operative BED and Bulimia Nervosa , .
The predominant purpose of the EDE-Q: BSV was to assess CHSP frequency and severity in the 28-days prior to participating in the study. Using an adapted version (Appendix A) of the eight items contained in the EDE-Q: BSV, participants answered three CHSP questions prior to surgery including:
Over the past four weeks have you chewed food and spit it out without swallowing it to influence your weight or shape (‘yes’ or ‘no’ response);
If yes, how many times have you done this in the past 28-days?;
How distressed have you been about chewing and spitting (0 = not at all; 6 = extreme).
Participants were asked all eight items related to CHSP at one-year follow up. It should be noted that due to participants having to follow a strict pre-surgery diet, which involves liquid protein drinks and little to no solid foods 3-4 weeks prior to surgery, question 1 and 2 of the EDE-Q: BSV (CHSP section) were modified from the original version. Question 1 asked participants to indicate the presence or absence of CHSP, while question 2 did not request participants to list the foods consumed instead asked for an indication of CHSP frequency.
Hospital Anxiety and Depression Scale (HADS)
The Hospital Anxiety and Depression Scale (HADS) is a 14-item measure of both anxiety (7-items) and depression (7-items) symptomology, using a four-point Likert scale (from 3 = Yes, definitely to 0 = No, not at all); with questions 7 and 10 being reverse scored . Higher scores typically signify increased anxiety and depression symptomology,with domain scores ≥ 11 indicating clinical levels of anxiety or depression, and ≤ 7 indicating no anxiety or depression . The HADS has been well validated and in the current study, the measure had excellent internal reliability for both anxiety (α=0.85) and depression (α = 0.76) and had a total scale α of 0.88 at baseline.
Adherence to guidelines
Patient observation of the Norwegian National Dietary Guidelines  were assessed by indicating on a Likert scale what level (from 1 ‘some,’ to 7 ‘a lot’) of perceived adherence the patient had for different guideline items, including: 1. not going 3-4 hours between each meal,2. choosing low fat meat products; 3. choosing low fat dairy products; 4. using wholegrain products; 5. eating five portions of fruit/vegetables per day; and 6. limiting their intake of fat and sugar. The six guidelines asked of participants, were a condensed version of the full 12 items, which also included items on physical activity , .
Case presentation: patient-1
Patient-1 was a female aged 30 years old. Prior to vertical sleeve gastrectomy (VSG) surgery, her BMI was 41.5 kg/m2. Additionally, no prior lifetime or current psychiatric conditions were reported. Reported medicated comorbidities for patient-1 included hypothyroidism. It should be noted that patient-1 dropped out of the study at year-two follow-up.
Pre-operatively, patient-1 indicated engaging in CHSP twice in the 28 days prior to surgery with moderate distress attributed to the behaviour. CHSP had ceased at one-year follow-up. Binge eating frequency reduced significantly at one-year follow up (from score 6 to 1). The frequency and days of feeling a LoC increased at follow-up but were still considered 'low' (3 out of 28 days); Patient-1 indicated a strong adherence to national dietary guidelines pre-operatively, which increased marginally at follow-up. Anxiety and Depression symptomatology was well below clinical threshold both before and after surgery.
Scores are presented in Table 1.
Case presentation: patient-2
Patient-2 was a female aged 35 years old. Prior to Roux-en-Y Gastric Bypass (GBP) surgery, her BMI was 42.7 kg/m2. As part of the bariatric surgery screening process, patient-2 did not raise significant psychological or pathological eating concerns that warranted her exclusion from the procedure. Additionally, no prior lifetime or current psychiatric conditions were reported. No reported medicated comorbidities for patient-2 were noted.
Pre-operatively, patient-2 did not indicate any engagement in CHSP, however at one-year follow-up indicated to engaging in at least 10 episodes of CHSP in the 28-days prior. At two-year follow-up CHSP was still present, but had reduced to 4 episodes in the 28-days prior. Prior to surgery patient-2 indicated she had been engaging in 'moderate' bingeing (score of 4) but with no associated loss of control. Subjective bingeing ceased at one-year follow-up and at two-year follow-up had occurred only once in the prior 28-days. Number of days (10 out of 28) and severity of feeling a subjective LoC increased significantly but was still considered 'low' (3 out of 28 days); Patient-2 indicated a low adherence to national dietary guidelines pre-operatively, which increased to near perfect adherence at follow-ups. Anxiety and Depressive symptomatology was at non-clinical levels at follow-ups.
Scores are presented in Table 1.
Case presentation: patient-3
Patient-3 was a female aged 62 years old. Prior to Roux-en-Y GBP surgery, her BMI was 39.25kg/m2. As part of the bariatric surgery screening process, patient-3 did not raise significant psychological or pathological eating concerns that warranted her exclusion from the procedure. Patient-3 had previously been treated for an unspecified psychiatric disorder as an outpatient and was on antidepressant medication. Additionally, patient-3 was taking opioids for pain management, as well as medications for hypertension and hyperlipidaemia.
Pre-operatively, patient-3 indicated engagement in an unspecified amount of CHSP which ceased entirely post-operatively and was not reported at both follow-up timepoints. It should be noted that although patient 3 indicated to the presence of CHSP at baseline, they did not provide an amount for the frequency which they engaged in the behaviour. This was due to the questionnaires being self-report and not all questions being made mandatory or a requirement of treatment -clinical and research data was collected separately, through different processes.
Prior to surgery patient-3 indicated no bingeing or associated loss of control. This was also the case post-operatively at both follow-up timepoints. Patient-3 indicated a moderate adherence to national dietary guidelines pre-operatively, which appeared to increase further ' at one-year follow-up but had dropped slightly at the two-year mark. Anxiety and depressive symptomatology were at non-clinical (score < 7) levels pre- and post-operatively.
Scores are presented in Table 1.
The primary purpose of the current exploratory study was to examine CHSP and its relation to binge eating, dietary guideline adherence, as well as to anxiety and depression in a sample of bariatric surgery patients. At baseline, two patients reported engaging in CHSP which ceased following surgery, whereas one de-novo case of CHSP appeared postoperatively. Scores for anxiety and depression were stable or reduced from baseline to one year-follow up. Binge eating (with associated LoC) increased at one-year follow-up for all three CHSP cases. All three participants reported increased adherence to dietary guidelines. At two-year follow up, overall binge eating was reduced and reported adherence to dietary guidelines also dropped in all three patients. Furthermore, considering the point-prevalence of CHSP in the general population of adults is 0.4%  and taking into consideration the small clinical sample size of the current exploratory study, there may likely be some occurrence of CHSP behaviour among a larger bariatric population, which future studies may wish to investigate further.
In spite of assurances of anonymity and confidentiality, the participants may have hesitated to fully disclose pathological eating behaviours, including CHSP, in fear of the consequences for their forthcoming and scheduled surgery. Further, fear of judgment may have limited disclosure both prior to surgery and at follow-up appointments, as recent research has demonstrated that discussing CHSP is considered exceptionally taboo, even amongst more general samples , and therefore may be frequently underreported.
Putatively, it may be posited that some bariatric patients may use CHSP as a pre or post-operative coping strategy. Specifically, they may utilise CHSP as a means to adhere to pre-surgical liquid diet conditions and during post-surgical follow-up in response to the fear of causing complications, such as rupturing, in the gastrointestinal tract. Pathological eating behaviour in the post-operative period has the highest predictive value in determining an individual’s weight loss after bariatric surgery . CHSP may therefore impede weight loss in this patient group, but this has not been explored. CHSP may occur in the presence of LoC  and has even been suggested as a marker for ED severity . Additionally, CHSP may present a ‘cathartic outlet’  in lieu of an individual’s post-operatively limited ability to binge. However, our findings provide preliminary insight into CHSP occurring both pre- and post-surgery, and therefore warrants additional studies using larger samples.
A number of limitations were noted for the current study, which included single site data collection, rendering the ability to draw inferences and generalize results to a wider bariatric sample, not possible. Additionally, questions were entirely self-reported, with majority of questions not being ‘mandatory’, which led to missing data, particularly at baseline. This was despite clinical and research questions being collected independently of each other, and participants being reassured that research questionnaires had no bearing on the outcome of treatment or care received.
Further, other indicators of eating pathology were low in the cases explored in the current study. Such difference, when compared to parallel estimates found in the bariatric surgery literature, may indicate the possible presence of selection bias and underreporting. Further, the addition of five CHSP questions at follow-up meant that deeper insight into CHSP (based on EDE: BSV) could not be compared pre- and post- operatively, only post-operatively at the one- and two-year follow-ups.
Clinical significance and future research
Research investigating CHSP in bariatric surgery patients is limited. The current study provides a preliminary starting point for the exploration of CHSP as a pathological symptom of disordered eating in this sample. Moreover, given that participants may have been hesitant to be forthcoming about their CHSP behaviour, careful consideration of the approach to understanding CHSP in a bariatric population should also be given. Nonetheless, the use of a screening tools such as the EDE: BSV may provide useful, straightforward, and efficient examination of eating pathology in bariatric surgery patients, and overall has meaningful clinical utility.
When examining dietary guideline adherence, binge eating, CHSP, anxiety and depression in three cases drawn from a convenience sample of bariatric candidates, it was found that a small number of individuals reported engaging in CHSP behaviour (both pre-operatively, or post-operatively). Specifically, it was noted that in the bariatric surgery cases examined, CHSP occurred to some level both pre- and post-operatively. Future studies should examine CHSP in a larger and more robust sample.
Availability of data and materials
The datasets generated and/or analysed during the current study are not publicly available due to the on-going nature of the study. Data requests are at the discretion of the data owner and/or participating institutions. Initial requests may be sought by contacting the study lead Camilla.Lindvall.Dahlgren@bhioslo.no.
Binge Eating Disorder
Body Mass Index (kg/m2)
Case Report Guidelines
Chew and Spit
Eating Disorder Examination - Questionnaire
- EDE-Q: BSV:
Eating Disorder Examination - Questionnaire: Bariatric Surgery Version
Hospital Anxiety and Depression Scale
Loss of Control
Vertical Sleeve Gastrectomy
Aouad P, Hay P, Soh N, Touyz S. Chew and spit (CHSP): a systematic review. J Eat Disord. 2016;4(1):23.
Aouad P, Hay P, Soh N, Touyz S. Prevalence of chew and spit and its relation to other features of disordered eating in a community sample. Int J Eat Disord. 2018;51(8):968–72.
Aouad P, Hay P, Soh N, Touyz S, Mannan H, Mitchison D. Chew and spit (CHSP) in a large adolescent sample: prevalence, impact on health-related quality of life, and relation to other disordered eating features. Eat Disord. 2019;1–14.
Aouad P, Morad A, Hay P, Soh N, Touyz S, Rhodes P. Chew and spit (CHSP): an interpretative phenomenological analysis (IPA). Eat Behav. 2020;37:101388.
Burgmer R, Grigutsch K, Zipfel S, Wolf AM, de Zwaan M, Husemann B, Albus C, Senf W, Herpertz S. The influence of eating behavior and eating pathology on weight loss after gastric restriction operations. Obes Surg. 2005;15(5):684–91.
Conceição EM, Goldschmidt A. Disordered eating after bariatric surgery: clinical aspects, impact on outcomes, and intervention strategies. Curr Opin Psychiatry. 2019;32(6):504–9.
Cooper Z, Fairburn C. The eating disorder examination: a semi-structured interview for the assessment of the specific psychopathology of eating disorders. Int J Eat Disord. 1987;6(1):1–8.
D’Souza C, Hay P, Touyz S, Piya MK. Bariatric and cosmetic surgery in people with eating disorders. Nutrients. 2020;12(9):2861.
de Zwaan M, Hilbert A, Swan-Kremeier L, Simonich H, Lancaster K, Howell LM, Monson T, Crosby RD, Mitchell JE. Comprehensive interview assessment of eating behavior 18–35 months after gastric bypass surgery for morbid obesity. Surg Obes Relat Dis. 2010;6(1):79–85.
Devlin MJ, King WC, Kalarchian MA, Hinerman A, Marcus MD, Yanovski SZ, Mitchell JE. Eating pathology and associations with long-term changes in weight and quality of life in the longitudinal assessment of bariatric surgery study. Int J Eat Disord. 2018;51(12):1322–30.
Fairburn CG, Cooper Z, O'Connor ME. Eating Disorder Examination (Edition 16.0D). In: Fairburn CG ed. Cognitive behavior therapy and eating disorders. New York: The Guilford Press; 2008:265–308.
Fairburn CG, Beglin SJ. Eating Disorder Examination Questionnaire (EDE-Q 6.0). In: Fairburn CG ed. Cognitive behavior therapy and eating disorders. New York: The Guilford Press; 2008:309–13.
Grilo CM, Henderson KE, Bell RL, Crosby RD. Eating disorder examination-questionnaire factor structure and construct validity in bariatric surgery candidates. Obes Surg. 2013;23(5):657–62.
Guarda AS, Coughlin JW, Cummings M, Marinilli A, Haug N, Boucher M, Heinberg LJ. Chewing and spitting in eating disorders and its relationship to binge eating. Eat Behav. 2004;5(3):231–9.
Henriksen HB, Carlsen MH, Paur I, Berntsen S, Bøhn SK, Skjetne AJ, Kværner AS, Henriksen C, Andersen LF, Smeland S. Relative validity of a short food frequency questionnaire assessing adherence to the Norwegian dietary guidelines among colorectal cancer patients. Food Nutr Res. 2018;62:1–15.
Henriksen HB, Ræder H, Bøhn SK, Paur I, Kværner AS, Billington SÅ, Eriksen MT, Wiedsvang G, Erlund I, Færden A. The Norwegian dietary guidelines and colorectal cancer survival (CRC-NORDIET) study: a food-based multicentre randomized controlled trial. BMC Cancer. 2017;17(1):83.
Hrabosky JI, White MA, Masheb RM, Rothschild BS, Burke-Martindale CH, Grilo CM. Psychometric evaluation of the eating disorder examination-questionnaire for bariatric surgery candidates. Obesity. 2008;16(4):763–9.
Ivezaj V. Comment on: A modified inpatient eating disorders treatment protocol for post-bariatric surgery patients: patient characteristics and treatment response. Surg Obes Relat Dis. 2019;15(12):e37–9.
Ivezaj V, Kessler EE, Lydecker JA, Barnes RD, White MA, Grilo CM. Loss-of-control eating following sleeve gastrectomy surgery. Surg Obes Relat Dis. 2017;13(3):392–8.
LeMont D, Moorehead M, Parish M, Reto CS, Ritz SJ. Suggestions for the pre-surgical psychological assessment of bariatric surgery candidates. Am Soc Bariatr Surg. 2004;129:1–27.
Lin C-Y, Pakpour AH. Using Hospital Anxiety and Depression Scale (HADS) on patients with epilepsy: confirmatory factor analysis and Rasch models. Seizure. 2017;45:42–6.
Macias JG, Leal FV. Psychopathological differences between morbidly obese binge eaters and non-binge eaters after bariatric surgery. Eat Weight Disord Stud Anorex Bulim Obes. 2003;8(4):315–8.
Makhzoumi SH, Guarda AS, Schreyer CC, Reinblatt SP, Redgrave GW, Coughlin JW. Chewing and spitting: A marker of psychopathology and behavioral severity in inpatients with an eating disorder. Eat Behav. 2015;17:59–61. https://doi.org/10.1016/j.eatbeh.2014.12.012.
Meany G, Conceição E, Mitchell JE. Binge eating, binge eating disorder and loss of control eating: effects on weight outcomes after bariatric surgery. Eur Eat Disord Rev. 2014;22(2):87–91.
Mitchell JE, De Zwaan M. Bariatric surgery: a guide for mental health professionals. London: Taylor & Francis; 2005.
Mond JM, Hay PJ, Rodgers B, Owen C, Beumont P. Validity of the Eating Disorder Examination Questionnaire (EDE-Q) in screening for eating disorders in community samples. Behav Res Ther. 2004;42(5):551–67.
Niego SH, Kofman MD, Weiss JJ, Geliebter A. Binge eating in the bariatric surgery population: a review of the literature. Int J Eat Disord. 2007;40(4):349–59.
Oslo - Norway: Ministry of Health and Care Services. The Norwegian Dietary Guidelines. Norway: Norwegian Directorate of Health; 2014. Retrieved from https://www.helsedirektoratet.no/brosjyrer/helsedirektoratets-kostrad-brosjyre-og-plakat/Helsedirektoratets%20kostråd%20-%20engelsk.pdf. Accessed 1 Nov 2020.
Parker K, Mitchell S, O’Brien P, Brennan L. Psychometric evaluation of disordered eating measures in bariatric surgery candidates. Obes Surg. 2016;26(3):563–75.
Powers PS, Perez A, Boyd F, Rosemurgy A. Eating pathology before and after bariatric surgery: a prospective study. Int J Eat Disord. 1999;25(3):293–300.
Riley DS, Barber MS, Kienle GS, Aronson JK, von Schoen-Angerer T, Tugwell P, Gagnier JJ. CARE guidelines for case reports: explanation and elaboration document. J Clin Epidemiol. 2017;89:218–35.https://doi.org/10.1016/j.jclinepi.2017.04.026.
Smith KE, Orcutt M, Steffen KJ, Crosby RD, Cao L, Garcia L, Mitchell JE. Loss of control eating and binge eating in the 7 years following bariatric surgery. Obes Surg. 2019;29(6):1773–80.
Song YJ, Lee JH, Jung YC. Chewing and spitting out food as a compensatory behavior in patients with eating disorders. Compr Psychiatry. 2015;62:147–51. https://doi.org/10.1016/j.comppsych.2015.07.010.
Walø-Syversen G, Kvalem IL, Kristinsson J, Eribe IL, Rø Ø, Dahlgren CL. Executive function, eating behavior, and preoperative weight loss in bariatric surgery candidates: an observational study. Obes Facts. 2019;12(5):489–501.
Williams-Kerver GA, Steffen KJ, Mitchell JE. Eating pathology after bariatric surgery: an updated review of the recent literature. Curr Psychiatry Rep. 2019;21(9):86.
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scan. 1983;67(6):361–70.
This work was supported by a grant from Health Region South-East (027, 2017). The funding source had no involvement in the research project.
Ethics approval and consent to participants
The study conformed to the ethical norms and standards in the Declaration of Helsinki, and was approved by the Regional Committee for Medical and Health Research Ethics of South-Eastern Norway (Ref. 2015/4012) and the Privacy Ombudsman for Research at Oslo University Hospital. Informed consent was obtained for all study participants
Consent for publication
Participants have signed informed consent acknowledging that non-identifying information may be presented in publications.
The authors declare they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Aouad, P., Stedal, K., Walø-Syversen, G. et al. Chew and spit (CHSP) in bariatric patients: a case series. J Eat Disord 9, 89 (2021). https://doi.org/10.1186/s40337-021-00441-5
- Case report
- Case series
- Chew and spit
- Weight loss surgery